Furthermore, Brand and colleagues demonstrated that AXL is involved in acquired resistance to cetuximab in models of head and neck squamous cell carcinoma (HNSCC), in which it was overexpressed, activated and tightly associated with EGFR expression in cancer cells resistant to cetuximab [30]. This evidence concerns the gene EGFR and cancer.